An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
Clinical trial NCT05025241 · COMPLETED
Trial details
- NCT number
- NCT05025241
- Sponsor
- Neuren Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2023-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.